Lisinopril: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
Helen (talk | contribs)
Line 136: Line 136:
Lisinopril does not undergo metabolism and is excreted entirely unchanged into the urine. On multiple dosing lisinopril has an effective half-life of 12.6 hours. The clearance of lisinopril in healthy subjects is approximately 50 ml/min.  
Lisinopril does not undergo metabolism and is excreted entirely unchanged into the urine. On multiple dosing lisinopril has an effective half-life of 12.6 hours. The clearance of lisinopril in healthy subjects is approximately 50 ml/min.  


</u>Renal impairment</u>
<u>Renal impairment</u>
Impaired renal function decreases elimination of lisinopril, which is excreted via the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 ml/min.
Impaired renal function decreases elimination of lisinopril, which is excreted via the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 ml/min.

Revision as of 23:01, 21 August 2022


Pronunciation

Lisinopril 10mg

Lisinopril 20mg

Lisinopril 5mg

Generic Name: Lisinopril
Class: Cardiovascular Drug
Subclass: ACE inhibitors
Legal Classification: P1S1S3

Drug Names

Generic Name 藥物化學名稱 HA Code 藥物代碼 Legal Classification法律藥物分類 Brand Name 藥名
Lisinorpil Tablet 5mg LISI01 P1S1S3
Lisinorpil Tablet 10mg LISI02 P1S1S3
Lisinorpil Tablet 20mg LISI03 P1S1S ZESTRIL

Mechanism of Action

Lisinopril is an inhibitor of angiotensin-I converting enzyme (ACE inhibitor). The beneficial effects of ACE inhibitors appear to result primarily from the suppression of the plasma renin-angiotensin-aldosterone system. Renin is synthesized by the kidneys and released into the circulation where it converts angiotensinogen to angiotensin-I. Angiotensin-I is then converted by angiotensin converting enzyme to angiotensin-II. Angiotensin-II is a potent vasoconstrictor responsible for arterial vasoconstriction and increased blood pressure, as well as for stimulation of the adrenal gland to secrete aldosterone. Inhibition of ACE results in decreased plasma angiotensin-II, which leads to decreased vasopressor activity and to reduced aldosterone secretion. The latter decrease may result in an increase in serum potassium concentration. Lisinopril is used in the treatment of hypertension and heart failure. It also improves your survival if you are taking it after a recent heart attack of for heart failure. It works by widening your blood vessels and making it easier for your heart to pump blood around your body. It can also be used for diabetic kidney disease, to slow down the disease.

Lisinopril comes as tablet.

Route of Administration

Lisinopril is administered orally in a single daily dose. The absorption of Lisinopril tablet is not affected by food.

Dosage

Hypertension

Adult: initially 10 mg once daily; maintenance 20 mg once daily; maximum 80 mg/day.

Heart failure

Adult: initially 2.5 mg once daily, increased in steps of up to 10 mg at least every 2 weeks; maximum 35 mg per day if tolerated.

Diabetic kidney disease 10 mg to 20 mg once daily

The antihypertensive effects of lisinopril are seen within 1 to 2 hours of a single oral dose and the maximum effect occurs after about 6 hours, although the full effect may not develop for several weeks during chronic dosing.

The haemodynamic action lasts for about 24 hours after once-daily dosing.

Side Effects

System Organ Class Frequency Adverse reactions
Nervous system disorders Common Dizziness, headache,
Uncommon Confusion, sleep disturbances
Respiratory disorders Common Dry, itickly (non-productive) cough, dyspnoea
Skin disorders Uncommon Itching or a mild skin rash
rare Alopecia, oedema of the face, extremities, lips, tongue, glottis, and/or larynx
Gastro-intestinal disorders Common vomiting, diarrhoea
Uncommon Nausea, abdominal pain and indigestion
Rare Dry mouth
Very rare Glossitis, pancreatitis
Cardiac disorders UnCommon Palpitations, tachycardia
Vascular disorder common Hypotension
Uncommon Raynaud’s syndrome

Pharmacokinetics

Following oral administration of lisinopril, peak serum concentrations occur within about 7 hours, although there was a trend to a small delay in time taken to reach peak serum concentrations in acute myocardial infarction patients. Lisinopril absorption is not affected by the presence of food. Lisinopril does not undergo metabolism and is excreted entirely unchanged into the urine. On multiple dosing lisinopril has an effective half-life of 12.6 hours. The clearance of lisinopril in healthy subjects is approximately 50 ml/min.

Renal impairment Impaired renal function decreases elimination of lisinopril, which is excreted via the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 ml/min.